World's Best Scientists 2026 revealed!
Luciano Zardi

Luciano Zardi

Award Badge
Biology and Biochemistry
Switzerland
2023

D-Index & Metrics

Biology and Biochemistry

D-Index
75
Citations
22578
World Ranking
5266
National Ranking
103

Research.com Recognitions

  • 2023 - Research.com Biology and Biochemistry in Switzerland Leader Award

Overview

Luciano Zardi is affiliated with ETH Zurich in Switzerland. Their research contributions focus on areas related to pharmaceutical sciences and targeted nanoparticle therapy.

The scientist's recent publication record includes the paper titled "L19-Conjugated Gold Nanoparticles for the Specific Targeting of EDB-Containing Fibronectin in Neuroblastoma", published in 2025 in the journal Pharmaceutics.

Frequent collaborators in their research projects include:

  • Chiara Barisione
  • Silvia Ortona
  • Veronica Bensa
  • Caterina Ivaldo
  • Eleonora Ciampi

Publication venues where Luciano Zardi has contributed include:

  • Pharmaceutics

Best Publications

  • Blue silver: A very sensitive colloidal Coomassie G‐250 staining for proteome analysis

    Giovanni Candiano;Maurizio Bruschi;Luca Musante;Laura Santucci

  • The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1

    Guido Serini;Marie Luce Bochaton-Piallat;Patricia Ropraz;Antoine Geinoz

  • Design and Use of a Phage Display Library: HUMAN ANTIBODIES WITH SUBNANOMOLAR AFFINITY AGAINST A MARKER OF ANGIOGENESIS ELUTED FROM A TWO-DIMENSIONAL GEL *

    Alessandro Pini;Francesca Viti;Annalisa Santucci;Barbara Carnemolla

  • CIITA-Induced MHC Class II Expression in Mammary Adenocarcinoma Leads to a Th1 Polarization of the Tumor Microenvironment, Tumor Rejection, and Specific Antitumor Memory

    Lorenzo Mortara;Patrizia Castellani;Raffaella Meazza;Giovanna Tosi

  • Membrane‐Type Matrix Metalloproteinases 1 and 2 Exhibit Broad‐Spectrum Proteolytic Capacities Comparable to Many Matrix Metalloproteinases

    Marie‐Pia D'ortho;Horst Will;Susan Atkinson;Georgina Butler

  • The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction.

    Vera Knäuper;Susan Cowell;Bryan Smith;Carlos López-Otin

  • Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin.

    Laura Borsi;Enrica Balza;Marco Bestagno;Patrizia Castellani

  • Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon.

    L. Zardi;B. Carnemolla;A. Siri;T. E. Petersen

  • A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors.

    B Carnemolla;E Balza;A Siri;L Zardi

  • Immunoscintigraphic Detection of the ED-B Domain of Fibronectin, a Marker of Angiogenesis, in Patients with Cancer

    Monica Santimaria;Giovanni Moscatelli;Giuseppe L. Viale;Leonardo Giovannoni

  • The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis.

    Patrizia Castellani;Giuseppe Viale;Alessandra Dorcaratto;Guido Nicolo

  • Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform.

    Dario Neri;Barbara Carnemolla;Ahuva Nissim;Alessandra Leprini

  • Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix

    Barbara Carnemolla;Laura Borsi;Enrica Balza;Patrizia Castellani

  • Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.

    C. Halin;S. Rondini;F. Nilsson;A. Berndt

  • The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form.

    H. Stanton;J. Gavrilovic;S.J. Atkinson;M.P. d'Ortho

  • Selective targeted delivery of TNFα to tumor blood vessels

    Laura Borsi;Enrica Balza;Barbara Carnemolla;Francesca Sassi

  • Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis.

    Francesca Viti;Lorenzo Tarli;Leonardo Giovannoni;Luciano Zardi

  • Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice.

    Fredrik Nilsson;Hartwig Kosmehl;Luciano Zardi;Dario Neri

  • Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues.

    T. Vartio;L. Laitinen;O. Narvanen;M. Cutolo

  • A high-affinity human antibody that targets tumoral blood vessels

    Lorenzo Tarli;Enrica Balza;Enrica Balza;Francesca Viti;Francesca Viti;Laura Borsi;Laura Borsi

Frequent Co-Authors

Dario Neri
Dario Neri Philogen (Italy)
Antti Vaheri
Antti Vaheri University of Helsinki
Gillian Murphy
Gillian Murphy University of Cambridge
Maurizio Cutolo
Maurizio Cutolo University of Genoa
Pier Giorgio Natali
Pier Giorgio Natali PharmaMab S.r.l.
Silvano Ferrini
Silvano Ferrini University of Genoa
Roberto S. Accolla
Roberto S. Accolla University of Insubria
Greg Winter
Greg Winter University of Cambridge
Ismo Virtanen
Ismo Virtanen University of Helsinki
Raffaella Giavazzi
Raffaella Giavazzi Mario Negri Institute for Pharmacological Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Luciano Zardi

Trending Scientists

Recently Published Articles